 |
|
|
| |
Simtuzumab, an Antifibrotic Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2) Enzyme, Is Safe and Well Tolerated in Patients With Liver Disease
|
| |
| |
Reported by Jules Levin
EASL 2013 April Amsterdam
Andrew H. Talal1,2, Marlene Feron-Rigodon1, Jeannine Madere3, Xiaoru Wu3, G. Mani Subramanian3, Jeffrey D. Bornstein3
1Weill-Cornell Medical College, New York, NY, USA; 2SUNY-Buffalo, Buffalo, NY, USA; 3Gilead Sciences, Inc., Foster City, CA, USA
|
| |
|
|
|
|
|
